Comparison of long-term efficacy and safety between cilostazol and clopidogrel in chronic ischemic stroke: a nationwide cohort study.
Tsong-Hai LeeYu-Sheng LinChia-Wei LiouJiann-Der LeeTsung-I PengChi-Hung LiuPublished in: Therapeutic advances in chronic disease (2020)
The present real-world study demonstrated no significant difference in efficacy and safety between cilostazol and clopidogrel in chronic IS. However, cilostazol might be better than clopidogrel in patients with a history of hypertension or gastrointestinal bleeding.